Agenus Inc. (AGEN) 2007年年度报告「NASDAQ」.pdf

《Agenus Inc. (AGEN) 2007年年度报告「NASDAQ」.pdf》由会员分享，可在线阅读，更多相关《Agenus Inc. (AGEN) 2007年年度报告「NASDAQ」.pdf（235页珍藏版）》请在三个皮匠报告上搜索。

1、 Morningstar Document Research FORM 10-KAGENUS INC-AGENFiled:March 17,2008(period:December 31,2007)Annual report with a comprehensive overview of the companyThe information contained herein may not be copied,adapted or distributed and is not warranted to be accurate,complete or timely.The userassume

2、s all risks for any damages or losses arising from any use of this information,except to the extent such damages or losses cannot belimited or excluded by applicable law.Past financial performance is no guarantee of future results.Table of Contents UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWash

3、ington,D.C.20549 Form 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934For the fiscal year ended December 31,2007or TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF1934For the transition period from to Commission File Number:00

4、0-29089Antigenics Inc.(exact name of registrant as specified in its charter)Delaware 06-1562417(State or other jurisdiction ofincorporation or organization)(I.R.S.EmployerIdentification No.)162 Fifth Avenue,Suite 900,New York,New York 10010(Address of principal executive offices,including zip code)R

5、egistrants telephone number,including area code:(212)994-8200Securities registered pursuant to Section 12(b)of the Act:Common Stock,$.01 Par Value The NASDAQ Global Market(Title of each class)(Name of each exchange on which registered)Securities registered pursuant to Section 12(g)of the Act:NoneInd

6、icate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405 of the Securities Act.Yes No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Act.Yes No Indicate by check mark whether the registrant(1)